Royalty Pharma (RPRX) came out with quarterly earnings of $1.17 per share, beating the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $1.04 per share a year ago. These ...
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Royalty Pharma (RPRX), which belongs to the Zacks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback